Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
IDELALISIB PLUS AN ANTI-CD20 ANTIBODY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WHO ARE HBV CORE ANTIBODY POSITIVE: SIMILAR PATTERNS OF LIVER TEST ABNORMALITIES
Haematologica (2016)
  • T. Robak, Emory University
  • A. D. Zelenetz, Memorial Sloan Kettering Cancer Center
  • A. Mato, University of Pennsylvania
  • J. A. Jones, Ohio State University
  • J. M. Pagel, University of Washington
  • J. C. Barrientos
  • J. R. Brown, Harvard University
  • M. Montillo, Catholic University of the Sacred Heart
  • R. Dubowy
  • G. Xing
  • J. J. Li
  • T. J. Kipps, University of California, San Diego
  • P. Hillmen, Medical University of Łódź
Link
Disciplines
Publication Date
June 1, 2016
Citation Information
T. Robak, A. D. Zelenetz, A. Mato, J. A. Jones, et al.. "IDELALISIB PLUS AN ANTI-CD20 ANTIBODY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WHO ARE HBV CORE ANTIBODY POSITIVE: SIMILAR PATTERNS OF LIVER TEST ABNORMALITIES" Haematologica Vol. 101 (2016)
Available at: http://works.bepress.com/john-pagel/33/